Ro-40-5576

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRo-40-5576
Drug Alias NameRo-40-4388
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAspartic acid proteases inhibitors
TargetsAspartic acid proteases
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A